51 related articles for article (PubMed ID: 21980627)
21. Glutathione S-transferase (placental) as a marker of transformation in the human cervix uteri: an immunohistochemical study.
Randall BJ; Angus B; Akiba R; Hall A; Cattan AR; Proctor SJ; Jones RA; Horne CH
Br J Cancer; 1990 Oct; 62(4):614-8. PubMed ID: 2223578
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic value of clusterin immunostaining in hepatocellular carcinoma.
Li Y; Liu F; Zhou W; Zhang S; Chu P; Lin F; Wang HL
Diagn Pathol; 2020 Oct; 15(1):127. PubMed ID: 33054843
[TBL] [Abstract][Full Text] [Related]
23. Nicotinamide Phosphoribosyl Transferase a Reliable Marker of Progression in Cervical Dysplasia.
Vora M; Alattia LA; Ansari J; Ong M; Cotelingam J; Coppola D; Shackelford R
Anticancer Res; 2017 Sep; 37(9):4821-4825. PubMed ID: 28870901
[TBL] [Abstract][Full Text] [Related]
24. Analysis of Clusterin and Clusterin Receptors in the Endometrium and Clusterin Levels in Cervical Mucus of Endometriosis.
Konrad L; Hackethal A; Oehmke F; Berkes E; Engel J; Tinneberg HR
Reprod Sci; 2016 Oct; 23(10):1371-80. PubMed ID: 27071964
[TBL] [Abstract][Full Text] [Related]
25. Augmented Activity of Cyclooxygenase-2 in Tissue and Serum of Patients With Cervical Cancer.
Jawanjal P; Salhan S; Dhawan I; Das N; Aggarwal R; Tripathi R; Rath G
J Clin Lab Anal; 2016 Nov; 30(6):1198-1207. PubMed ID: 27292107
[TBL] [Abstract][Full Text] [Related]
26. Clusterin transcript variants expression in thyroid tumor: a potential marker of malignancy?
Fuzio P; Napoli A; Ciampolillo A; Lattarulo S; Pezzolla A; Nuzziello N; Liuni S; Giorgino F; Maiorano E; Perlino E
BMC Cancer; 2015 May; 15():349. PubMed ID: 25934174
[TBL] [Abstract][Full Text] [Related]
27. Involucrin expression in cervical intraepithelial neoplasia: a critical evaluation.
Elsayed A; Richart RM; Crum CP
Gynecol Oncol; 1987 Jan; 26(1):25-34. PubMed ID: 3792933
[TBL] [Abstract][Full Text] [Related]
28. Secreted clusterin in colon tumor cell models and its potential as diagnostic marker for colorectal cancer.
Rodríguez-Piñeiro AM; García-Lorenzo A; Blanco-Prieto S; Alvarez-Chaver P; Rodríguez-Berrocal FJ; Cadena MP; Martínez-Zorzano VS
Cancer Invest; 2012 Jan; 30(1):72-8. PubMed ID: 22236192
[TBL] [Abstract][Full Text] [Related]
29. Clusterin and neuropilin-2 as potential biomarkers of tumor progression in benzo[a]pyrene-transformed 16HBE cells xenografted nude mouse model.
Wang Y; Jia Y; Yan L; Fu J; Hao M; Chen W; Yao B; Zhao P; Zhou Z
Chem Biol Interact; 2017 Sep; 275():145-151. PubMed ID: 28784314
[TBL] [Abstract][Full Text] [Related]
30. LINE-1 ORF1p is a Promising Biomarker in Cervical Intraepithelial Neoplasia Degree Assessment.
Karkas R; Abdullah KSA; Kaizer L; Ürmös Á; Raya M; Tiszlavicz L; Pankotai T; Nagy I; Mátés L; Sükösd F
Int J Gynecol Pathol; 2024 Jun; ():. PubMed ID: 38920137
[TBL] [Abstract][Full Text] [Related]
31. Gene expression profiling in sinonasal adenocarcinoma.
Tripodi D; Quéméner S; Renaudin K; Ferron C; Malard O; Guisle-Marsollier I; Sébille-Rivain V; Verger C; Géraut C; Gratas-Rabbia-Ré C
BMC Med Genomics; 2009 Nov; 2():65. PubMed ID: 19903339
[TBL] [Abstract][Full Text] [Related]
32. Fibroepithelial polyp of the uterine cervix.
Varga Z; Caduff R
Histopathology; 1999 Apr; 34(4):375-6. PubMed ID: 10231514
[No Abstract] [Full Text] [Related]
33. Clusterin role in hepatocellular carcinoma patients treated with oxaliplatin.
Wang X; Liu Y; Qin Q; Zheng T
Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32039450
[TBL] [Abstract][Full Text] [Related]
34. Effects of down-regulation of clusterin by small interference RNA on human acute myeloid leukemia cells.
Wang X; Liu R; Wang Y; Cai H; Zhang L
Int J Clin Exp Med; 2015; 8(11):20925-31. PubMed ID: 26885020
[TBL] [Abstract][Full Text] [Related]
35. Secretory clusterin contributes to oxaliplatin resistance by activating Akt pathway in hepatocellular carcinoma.
Xiu P; Dong X; Dong X; Xu Z; Zhu H; Liu F; Wei Z; Zhai B; Kanwar JR; Jiang H; Li J; Sun X
Cancer Sci; 2013 Mar; 104(3):375-82. PubMed ID: 23279642
[TBL] [Abstract][Full Text] [Related]
36. Knockdown of clusterin sensitizes pancreatic cancer cells to gemcitabine chemotherapy by ERK1/2 inactivation.
Tang Y; Liu F; Zheng C; Sun S; Jiang Y
J Exp Clin Cancer Res; 2012 Sep; 31(1):73. PubMed ID: 22967941
[TBL] [Abstract][Full Text] [Related]
37. Clusterin as a potential marker in distinguishing cervical neoplasia.
Lokamani I; Looi ML; Ali SA; Dali AZ; Jamal R
Anal Quant Cytol Histol; 2011 Aug; 33(4):223-8. PubMed ID: 21980627
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of clusterin expression in advanced-stage cervical cancer treated with curative intended radiotherapy.
Watari H; Kinoshita R; Han Y; Wang L; Hosaka M; Taguchi H; Tsuchiya K; Tanaka S; Shirato H; Sakuragi N
Int J Gynecol Cancer; 2012 Mar; 22(3):465-70. PubMed ID: 21633299
[TBL] [Abstract][Full Text] [Related]
39. The possible role of p53 and bcl-2 expression in cervical carcinomas and their premalignant lesions.
Dimitrakakis C; Kymionis G; Diakomanolis E; Papaspyrou I; Rodolakis A; Arzimanoglou I; Leandros E; Michalas S
Gynecol Oncol; 2000 Apr; 77(1):129-36. PubMed ID: 10739702
[TBL] [Abstract][Full Text] [Related]
40. Extracellular regulated kinase-2 immunoreactivity increases in parallel with cervical intraepithelial neoplasia grade in cervical neoplasia.
Kapetanios V; Lazaris AC; Bogris P; Kouneli S; Nonni A; Arvaniti H; Kouri E; Tzavara M; Giannakodimos G; Koutselini H; Patsouris ES
Int J Gynecol Cancer; 2008; 18(3):540-5. PubMed ID: 17961162
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]